Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 116 | NANETS2025 | Next issue

NANETS 2025

18th Annual Multidisciplinary NET Medical Symposium NANETS 2025

Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Previous section
Clinical – Chemo/SSA/Biologics
Table of contents
Next section
Clinical – Surgery/Applied Pathology

ea0116c12 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET)

ea0116c13 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Safety and clinical implications of concurrent biopsy of neuroendocrine liver metastases at the time of liver-directed therapy

ea0116c14 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Efficacy of 177Lu-edotreotide vs everolimus in patients with grade 1 or grade 2 GEP-NETs: Phase 3 COMPETE trial (post hoc subgroup analyses)

ea0116c15 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Long-term Follow-up of PRRT-Naïve Patients with GEP-NETs Treated with Targeted Alpha Therapy 212Pb-DOTAMTATE in the Phase 2 ALPHAMEDIX 02 Trial

ea0116c16 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Phase 2 Study of Targeted Alpha Therapy 212Pb-DOTAMTATE in Patients with Advanced Gastroenteropancreatic (GEP)-NETs Previously Treated with PRRT

ea0116c17 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

61Cu-NODAGA-LM3 versus 68Ga-DOTATOC in the same patients with neuroendocrine tumors: Preliminary results of the Phase I/II COPPER-PET-in-NET Trial

ea0116c18 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Patient Characteristics and Treatment Patterns With [177Lu]Lu-DOTA-TATE (177Lu-DOTATATE) In the US: A Real-World Assessment

ea0116c19 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

[212Pb]VMT-alpha-NET for advanced SSTR+ NETs: safety and preliminary efficacy results from cohorts 1 and 2 of the dose escalation phase

ea0116c20 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Multi-center NCI-sponsored phase 1 study of triapine in combination with 177Lu-dotatate in patients with progressive well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

ea0116c21 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Single institution experience with [131I]MIBG for pheochromocytoma and paraganglioma: Long-term outcomes and dosimetry

ea0116c22 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Systematic Literature Review and Radiomics Quality Assessment for Lung, Adrenal, Thyroid and Pituitary Neuroendocrine Tumors

ea0116c23 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Efficacy and safety of [177Lu]Lu-edotreotide ([177Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumors (NETs) – a systematic literature review (SLR) and meta-analysis

ea0116c25 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease

ea0116c26 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Clinical outcomes following salvage PRRT in patients with metastatic neuroendocrine tumors

ea0116c27 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Efficacy and Safety of Peptide Receptor Radionuclide Therapy Retreatment (r-PRRT) Practices in Progressive Neuroendocrine Tumors (prog-NETs): Systematic Review and Meta-Analysis

ea0116c28 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Abstract unavailable

ea0116c29 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Correlation of dosimetry and toxicity for Lu177-DOTATATE in GEP-NETs

ea0116c30 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

DISCO: Safety, Tolerability and Diagnostic performance of 64Cu-SARTATE compared to 68Ga-DOTATATE in patients with known or suspected neuroendocrine tumors

ea0116c31 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Abstract unavailable

ea0116c32 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Incidence of Peripheral Inserted Central Line Complications with Administration of 177Lutetium Dotatate

ea0116c33 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Somatostatin receptor expression on 68Ga-Dotatate imaging among patients with poorly differentiated extra-pulmonary neuroendocrine carcinomas: a prospective study

ea0116c34 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Outcomes of Peptide Receptor Radionuclide Therapy in Patients with Pheochromocytoma and Paraganglioma: A Center of Excellence Experience

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2026 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more